Cynosure Group LLC Decreases Stock Holdings in Arm Holdings plc (NASDAQ:ARM)

Cynosure Group LLC lowered its stake in Arm Holdings plc (NASDAQ:ARM) by 14.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,193 shares of the company’s stock after selling 359 shares during the quarter. Cynosure Group LLC’s holdings in ARM were worth $271,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Charles Schwab Investment Management Inc. raised its position in ARM by 89.3% in the third quarter. Charles Schwab Investment Management Inc. now owns 18,457 shares of the company’s stock worth $2,640,000 after acquiring an additional 8,707 shares during the period. Quantbot Technologies LP purchased a new stake in shares of ARM in the 3rd quarter worth $52,000. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in ARM by 318.7% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,589 shares of the company’s stock worth $799,000 after purchasing an additional 4,254 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in ARM by 79.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,550 shares of the company’s stock valued at $937,000 after purchasing an additional 2,900 shares in the last quarter. Finally, Rockefeller Capital Management L.P. increased its position in ARM by 18.4% in the third quarter. Rockefeller Capital Management L.P. now owns 15,354 shares of the company’s stock worth $2,196,000 after buying an additional 2,386 shares in the last quarter. 7.53% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Loop Capital lifted their price objective on ARM from $180.00 to $195.00 and gave the company a “buy” rating in a research report on Monday, February 10th. Barclays upped their price target on shares of ARM from $145.00 to $155.00 and gave the stock an “overweight” rating in a research report on Friday, January 17th. Cfra Research upgraded shares of ARM to a “hold” rating in a research report on Friday, March 21st. Evercore ISI upped their target price on shares of ARM from $176.00 to $202.00 and gave the stock an “outperform” rating in a report on Thursday, February 6th. Finally, Susquehanna raised their price target on ARM from $118.00 to $140.00 and gave the company a “neutral” rating in a report on Wednesday, January 22nd. Two research analysts have rated the stock with a sell rating, six have issued a hold rating, nineteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, ARM presently has a consensus rating of “Moderate Buy” and a consensus target price of $163.41.

ARM Price Performance

NASDAQ:ARM opened at $87.71 on Friday. The firm has a market capitalization of $91.91 billion, a price-to-earnings ratio of 115.41, a PEG ratio of 6.33 and a beta of 4.77. The business has a 50 day simple moving average of $133.89 and a 200-day simple moving average of $139.28. Arm Holdings plc has a 1 year low of $84.39 and a 1 year high of $188.75.

About ARM

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries.